MedTrace Logo

Transcranial Direct Current Stimulation in a Smoking Cessation Trial

NCT01710410 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2016-06-13

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of transcranial direct current stimulation (tDCS) plus nicotine patch as a viable smoking cessation program for nicotine dependent smokers.

Conditions

  • Nicotine Dependence

Interventions

DEVICE

active transcranial Direct Current Stimulation

Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp.

DEVICE

sham transcranial Direct Current Stimulation

Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp.

Sponsors & Collaborators

  • Nuraleve, Inc.

    collaborator INDUSTRY

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Laurie Zawertailo, Ph.D. · Centre for Addiction and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01710410 on ClinicalTrials.gov